phosphonoacetic acid has been researched along with transforming growth factor beta in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, A; Jin, H; Wright, JA | 1 |
| Glick, AB; Quan, W; Weinberg, WC; Wu, IH; Yuspa, SH | 1 |
| Ahmed Ansari, M; Chandran, B; Chikoti, L; Kumar, B; Pisano, G; Roy, A | 1 |
3 other study(ies) available for phosphonoacetic acid and transforming growth factor beta
| Article | Year |
|---|---|
Drug resistance and gene amplification potential regulated by transforming growth factor beta 1 gene expression.
Topics: Animals; Antineoplastic Agents; Aspartic Acid; Blotting, Southern; Cell Division; Cell Line; Drug Resistance; Gene Amplification; Gene Expression; Mice; Phosphonoacetic Acid; Recombinant Proteins; Swine; Transfection; Transforming Growth Factor beta; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1995 |
Transforming growth factor beta 1 suppresses genomic instability independent of a G1 arrest, p53, and Rb.
Topics: Animals; Aspartic Acid; Cells, Cultured; G1 Phase; Gene Amplification; Genes, p53; Genes, Retinoblastoma; Mice; Phosphonoacetic Acid; Transforming Growth Factor beta | 1996 |
Interferon-γ-inducible protein 16 (IFI16) is required for the maintenance of Epstein-Barr virus latency.
Topics: Burkitt Lymphoma; Cell Line, Tumor; Epstein-Barr Virus Infections; Gene Expression Regulation; Gene Knockdown Techniques; Genome, Viral; Herpesvirus 4, Human; Host-Pathogen Interactions; Humans; Nuclear Proteins; Phosphonoacetic Acid; Phosphoproteins; Tetradecanoylphorbol Acetate; Transforming Growth Factor beta; Viral Proteins; Virus Activation; Virus Latency | 2017 |